Life Sciences & Biomedicine Nutrition & Dietetics Science & Technology
Purpose To examine the prospective association between serum Mg level and the incidence of cognitive impairment.
Methods A random sub-cohort (n = 2063) from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort was included in this study. Baseline serum Mg concentration was measured using inductively coupled plasma mass spectrometry. According to the current reference interval of serum magnesium (0.75-0.95 mmol/L), we classified participants below the interval as Level 1 and used it as the referent. The rest of the study population were equally divided into three groups, named Level 2 to 4. Incident cognitive impairment was identified using the Six-Item Screener. Multivariable-adjusted odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated using logistic regression models.
Results After adjustment for potential confounders, an inverse threshold association between serum Mg level and incident cognitive impairment was observed. Compared to those with hypomagnesemia (Level 1: < 0.75 mmol/L), the relative odds of incident cognitive impairment was reduced by 41% in the second level [OR (95% CI) = 0.59 (0.37, 0.94)]; higher serum Mg level did not provide further benefits [Level 3 and 4 versus Level 1: OR (95% CI) = 0.54 (0.34, 0.88) and 0.59 (0.36, 0.96), P for linear trend = 0.08].
Conclusions Findings from this prospective study suggest that sufficient Mg status within the normal range may be beneficial to cognitive health in the US general population.
Serum magnesium concentration and incident cognitive impairment: the reasons for geographic and racial differences in stroke study
Creators
Cheng Chen - Columbia University Medical Center
Pengcheng Xun - Indiana University Bloomington
Frederick Unverzagt - Indiana University
Leslie A. McClure - Drexel University
Marguerite Ryan Irvin - University of Alabama at Birmingham
Suzanne Judd - University of Alabama at Birmingham
Mary Cushman - University of Vermont
Ka He - Columbia Univ, Irving Med Ctr, Dept Obstet & Gynecol, 622 W 168th St,Suite 16-62, New York, NY 10032 USA
Publication Details
European journal of nutrition, v 60(3), pp 1511-1520
Publisher
Springer Nature
Number of pages
10
Grant note
U01-NS-041588 / Department of Health and Human Services
R01AG056111 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
National Institute of Neurological Disorders and Stroke, National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
U01-DP-006302 / Centers for Disease Control and Prevention; United States Department of Health & Human Services; Centers for Disease Control & Prevention - USA
Resource Type
Journal article
Language
English
Academic Unit
Epidemiology and Biostatistics
Web of Science ID
WOS:000554332200001
Scopus ID
2-s2.0-85088785341
Other Identifier
991019168294404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: